108 related articles for article (PubMed ID: 31755335)
1. Rational discovery of novel type-III FTF antagonists to competitively suppress TIF-2 coactivation in liver cancer.
Xu L; Chen Z; Shao K; Wang Y; Cui L; Guo N
J Recept Signal Transduct Res; 2019 Aug; 39(4):304-311. PubMed ID: 31755335
[TBL] [Abstract][Full Text] [Related]
2. High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.
Hua Y; Shun TY; Strock CJ; Johnston PA
Assay Drug Dev Technol; 2014 Sep; 12(7):395-418. PubMed ID: 25181412
[TBL] [Abstract][Full Text] [Related]
3. The hepatitis B virus core promoter is strongly activated by the liver nuclear receptor fetoprotein transcription factor or by ectopically expressed steroidogenic factor 1.
Gilbert S; Galarneau L; Lamontagne A; Roy S; Bélanger L
J Virol; 2000 Jun; 74(11):5032-9. PubMed ID: 10799577
[TBL] [Abstract][Full Text] [Related]
4. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.
Chen R; Wan J; Song J; Qian Y; Liu Y; Gu S
Pharm Biol; 2017 Dec; 55(1):503-509. PubMed ID: 27937122
[TBL] [Abstract][Full Text] [Related]
5. Discovery of new non-steroidal farnesoid X receptor modulators through 3D shape similarity search and structure-based virtual screening.
Wang L; Si P; Sheng Y; Chen Y; Wan P; Shen X; Tang Y; Chen L; Li W
Chem Biol Drug Des; 2015 Apr; 85(4):481-7. PubMed ID: 25228339
[TBL] [Abstract][Full Text] [Related]
6. In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α.
Singh K; Munuganti RS; Leblanc E; Lin YL; Leung E; Lallous N; Butler M; Cherkasov A; Rennie PS
Breast Cancer Res; 2015 Feb; 17(1):27. PubMed ID: 25848700
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism for the potentiation of the transcriptional activity of human liver receptor homolog 1 by steroid receptor coactivator-1.
Xu PL; Liu YQ; Shan SF; Kong YY; Zhou Q; Li M; Ding JP; Xie YH; Wang Y
Mol Endocrinol; 2004 Aug; 18(8):1887-905. PubMed ID: 15143151
[TBL] [Abstract][Full Text] [Related]
8. Importance of the pharmacological profile of the bound ligand in enrichment on nuclear receptors: toward the use of experimentally validated decoy ligands.
Lagarde N; Zagury JF; Montes M
J Chem Inf Model; 2014 Oct; 54(10):2915-44. PubMed ID: 25250508
[TBL] [Abstract][Full Text] [Related]
9. High-Content Screening Campaign to Identify Compounds That Inhibit or Disrupt Androgen Receptor-Transcriptional Intermediary Factor 2 Protein-Protein Interactions for the Treatment of Prostate Cancer.
Fancher AT; Hua Y; Camarco DP; Close DA; Strock CJ; Johnston PA
Assay Drug Dev Technol; 2018; 16(6):297-319. PubMed ID: 30109944
[TBL] [Abstract][Full Text] [Related]
10. Chemical Screening of Nuclear Receptor Modulators.
Ishigami-Yuasa M; Kagechika H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752136
[TBL] [Abstract][Full Text] [Related]
11. Structure-based virtual screening for novel ligands.
Pitt WR; Calmiano MD; Kroeplien B; Taylor RD; Turner JP; King MA
Methods Mol Biol; 2013; 1008():501-19. PubMed ID: 23729265
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the retinoid orphan-related receptor-alpha coactivator binding interface: a structural basis for ligand-independent transcription.
Harris JM; Lau P; Chen SL; Muscat GE
Mol Endocrinol; 2002 May; 16(5):998-1012. PubMed ID: 11981035
[TBL] [Abstract][Full Text] [Related]
13. A quantitative high-throughput screen identifies novel inhibitors of the interaction of thyroid receptor beta with a peptide of steroid receptor coactivator 2.
Johnson RL; Hwang JY; Arnold LA; Huang R; Wichterman J; Augustinaite I; Austin CP; Inglese J; Guy RK; Huang W
J Biomol Screen; 2011 Jul; 16(6):618-27. PubMed ID: 21482722
[TBL] [Abstract][Full Text] [Related]
14. FTF and LRH-1, two related but different transcription factors in human Caco-2 cells: their different roles in the regulation of bile acid transport.
Pan DH; Chen F; Neimark E; Li X; Shneider BL
Biochim Biophys Acta; 2005 Dec; 1732(1-3):31-7. PubMed ID: 16469397
[TBL] [Abstract][Full Text] [Related]
15. FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade.
Li H; Chen F; Shang Q; Pan L; Shneider BL; Chiang JY; Forman BM; Ananthanarayanan M; Tint GS; Salen G; Xu G
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G60-6. PubMed ID: 15591588
[TBL] [Abstract][Full Text] [Related]
16. Mimicking Intermolecular Interactions of Tight Protein-Protein Complexes for Small-Molecule Antagonists.
Xu D; Bum-Erdene K; Si Y; Zhou D; Ghozayel MK; Meroueh SO
ChemMedChem; 2017 Nov; 12(21):1794-1809. PubMed ID: 28960868
[TBL] [Abstract][Full Text] [Related]
17. An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2.
Meirson T; Samson AO; Gil-Henn H
Drug Des Devel Ther; 2017; 11():1535-1557. PubMed ID: 28572720
[TBL] [Abstract][Full Text] [Related]
18. Exploring dual inhibitors for STAT1 and STAT5 receptors utilizing virtual screening and dynamics simulation validation.
Raj U; Kumar H; Gupta S; Varadwaj PK
J Biomol Struct Dyn; 2016 Oct; 34(10):2115-29. PubMed ID: 26471877
[TBL] [Abstract][Full Text] [Related]
19. In silico identification of inhibitors targeting N-Terminal domain of human Replication Protein A.
Çınaroğlu SS; Timuçin E
J Mol Graph Model; 2019 Jan; 86():149-159. PubMed ID: 30366191
[TBL] [Abstract][Full Text] [Related]
20. Identification of sumoylation inhibitors targeting a predicted pocket in Ubc9.
Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
J Chem Inf Model; 2014 Oct; 54(10):2784-93. PubMed ID: 25191977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
